Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension

J Neurochem. 2009 Sep;110(6):1908-20. doi: 10.1111/j.1471-4159.2009.06281.x. Epub 2009 Jul 17.

Abstract

Neural stem cells constitute a promising source of cells for transplantation in Parkinson's disease, but a protocol for controlled dopaminergic differentiation is not yet available. Here we investigated the effect of the anti-apoptotic protein Bcl-x(L) and oxygen tension on dopaminergic differentiation and survival of a human ventral mesencephalic stem cell line (hVM1). hVM1 cells and a Bcl-x(L) over-expressing subline (hVMbcl-x(L)) were differentiated by sequential treatment with fibroblast growth factor-8, forskolin, sonic hedgehog, and glial cell line-derived neurotrophic factor. After 10 days at 20% oxygen, hVMbcl-x(L) cultures contained proportionally more tyrosine hydroxylase(TH)-positive cells than hVM1 control cultures. This difference was significantly potentiated from 11 +/- 0.8% to 17.2 +/- 0.2% of total cells when the oxygen tension was lowered to 3%. Immunocytochemistry and Q-PCR-analysis revealed expression of several dopaminergic markers besides of TH just as dopamine was detected in the culture medium by HPLC analysis. Although Bcl-x(L)-over-expression reduced cell death in the cultures, it did not alter the relative content of GABAergic, neurons, while the content of astroglial cells was reduced in hVMbcl-x(L) cell cultures compared with control. We conclude that Bcl-x(L) and lowered oxygen tension act in concert to enhance dopaminergic differentiation and survival of human neural stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis Inducing Factor / metabolism
  • Bromodeoxyuridine / metabolism
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • Cell Count
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology*
  • Cells, Cultured
  • Chromatography, High Pressure Liquid / methods
  • Colforsin / pharmacology
  • Dibutyryl Cyclic GMP / pharmacology
  • Dopamine / metabolism*
  • Embryonic Stem Cells / physiology*
  • Fetus
  • Gene Expression / drug effects
  • Green Fluorescent Proteins / genetics
  • HN Protein / metabolism
  • Humans
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Ionophores / pharmacology
  • L-Lactate Dehydrogenase / metabolism
  • Mesencephalon / cytology
  • Microtubule-Associated Proteins / metabolism
  • Neurons / physiology*
  • Oxygen / pharmacology*
  • Phorbol Esters / pharmacology
  • Transfection / methods
  • Tyrosine 3-Monooxygenase / metabolism
  • bcl-X Protein / genetics
  • bcl-X Protein / physiology*

Substances

  • AIFM1 protein, human
  • Apoptosis Inducing Factor
  • HN Protein
  • Intercellular Signaling Peptides and Proteins
  • Ionophores
  • MAP2 protein, human
  • Microtubule-Associated Proteins
  • Phorbol Esters
  • bcl-X Protein
  • Green Fluorescent Proteins
  • Colforsin
  • Dibutyryl Cyclic GMP
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • 12-O-retinoylphorbol-13-acetate
  • L-Lactate Dehydrogenase
  • Tyrosine 3-Monooxygenase
  • Bromodeoxyuridine
  • Oxygen
  • Dopamine